KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oscar Health (OSCR) Return on Sales (2020 - 2025)

Oscar Health's Return on Sales history spans 6 years, with the latest figure at 0.04% for Q4 2025.

  • For Q4 2025, Return on Sales rose 10.0% year-over-year to 0.04%; the TTM value through Dec 2025 reached 13.88%, up 1388.0%, while the annual FY2025 figure was 15.49%, 1549.0% down from the prior year.
  • Return on Sales reached 0.04% in Q4 2025 per OSCR's latest filing, up from 0.05% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 31.5% in Q1 2024 to a low of 296.27% in Q1 2021.
  • Average Return on Sales over 5 years is 13.92%, with a median of 0.07% recorded in 2022.
  • Peak YoY movement for Return on Sales: plummeted -29517bps in 2021, then skyrocketed 29619bps in 2022.
  • A 5-year view of Return on Sales shows it stood at 0.11% in 2021, then skyrocketed by 172bps to 0.08% in 2022, then plummeted by -253bps to 0.12% in 2023, then soared by 46bps to 0.06% in 2024, then surged by 162bps to 0.04% in 2025.
  • Per Business Quant, the three most recent readings for OSCR's Return on Sales are 0.04% (Q4 2025), 0.05% (Q3 2025), and 0.08% (Q2 2025).